Pellets header

Pellestisation is an agglomeration process, that converts fine powder-blend(s) & excipients into small-free flowing, spherical units referred to as PELLETS.

 

WHY PELLETS SHOULD BE PREFERRED

Excellent stabilityCompact structure Drug absorption Release of action at specially targeted site High active ingredient content possible Controlled release application These pellets avoid local irritation of GASTRO INTESTINAL TRACT(GIT) because the drugs doesn’t settle down at one place

 

ANTI-ALLERGIC

PRODUCT COMPOSITION
ANTI ALLERGIC
CETIRIZINE HYDROCHLORIDE 15%W/W PELLETS 15%

ANTI-BACTERIAL AGENT

PRODUCT COMPOSITION
ANTI BACTERIAL AGENT
MINOCYCLINE HYDROCHLORIDE 35% W/W PELLETS 35%

ANTI-CONVULSANT/ENZYME INHIBITOR

PRODUCT COMPOSITION
ANTI CONVULSANT/ENZYME INHIBITOR
VALPROIC ACID 58mg,87mg
SODIUM VALPORATE 133mg,200mg

ANALGESIC

PRODUCT COMPOSITION
Analgesic
ACECLOFENAC SODIUM 60% W/W SUSTAINED RELEASE PELLETS(FOR DOMESTIC & EXPORT) 60%
ACECLOFENAC SODIUM 40% W/W SUSTAINED RELEASE PELLETS(FOR DOMESTIC & EXPORT) 40%
DICLOFENAC SODIUM PELLET 40% w/w IN SUSTAINES RELEASE FORM 40%
DICLOFENAC POTASSIUM 50% W/W EXTENDED RELEASE PELLETS 50%
INDOMETHACIN EXTENDED RELEASE 30% W/W PELLETS 30%

ANTI-DEPRESANT

PRODUCT COMPOSITION
ANTI DEPRESANT
VENLAFAXINE HYDROCHLORIDE 25% SR 25%
DULOXETINE HYDROCHLORIDE 10 % W/W ENTERIC COATED PELLETS 10%

ANTI-EMETIC

PRODUCT COMPOSITION
ANTI-EMETIC
DOMPERIDONE(SUSTAINED RELEASE) PELLETS 20 mg
DOMPERIDONE(IMMEDIATE RELEASE) PELLETS 10 mg
DOMPERIDONEPELLETS (SUSTAINED RELEASE) 30mg

ANTI-FUNGAL AGENTS

PRODUCT COMPOSITION
Antifungal Agents
ITRACONAZOLE PELLETS 22% W/W 22%

ANTI-PLATELET

PRODUCT COMPOSITION
Anti-platelet
CLOPIDOGREL PELLETS 75 MG 75mg
CLOPIDROGREL PELLETS 50% W/W, 55% W/W 50,55%
ASPRIN 28% w/w, 60% w/w
ROSUVASTATIN 10mg(IR) PELLETS

ANTI-SPASMODIC

PRODUCT COMPOSITION
ANTI SPASMODIC
MEBEVERINE HYDROCHLORIDE 40% W/W SR PELLETS 40%

ANTI-ULCERANT

PRODUCT COMPOSITION
Anti-ulcerant
OMEPRAZOLE ENTERIC COATED PELLETS 8.5% W/W 8.50%
OMEPRAZOLE ENTERIC COATED PELLETS 15.0% W/W 15%
LANSOPRAZOLE ENTERIC COATED PELLETS 8.5% W/W 8.50%
LANSOPRAZOLE ENTERIC COATED PELLETS 10.0% W/W 10%
PANTOPRAZOLE ENTERIC COATED PELLETS 40mg 40mg
RABEPRAZOLE ENTERIC COATED PELLETS 20 MG 20mg
ESOMEPRAZOLE ENTERIC COATED PELLETS 40 MG 40mg
ESOMEPRAZOLE ENTERIC COATED PELLETS 20 MG 20mg

CARDIO VASCULAR

PRODUCT COMPOSITION
Cardio Vascular
ATORVASTATIN PELLETS 10MG, 20MG 10,20mg

EXPECTORANT

PRODUCT COMPOSITION
EXPECTORANT
AMBROXOL HYDROCHLORIDE 40% W/W PELLETS 40%

GOUTSUPRESSANT, ENZYME INHIBITOR, ANTI METABOLITE

PRODUCT COMPOSITION
GOUTSUPRESSANT, ENZYME INHIBITOR, ANTI METABOLITE
ALLOPURINOL 70% W/W SUSTAINED RELEASE PELLETS 70%

HYPOLIPIDEMIC AGENT

PRODUCT COMPOSITION
HYPOLIPIDEMIC AGENT
FENOFIBRATE 66% W/W PELLETS 66%

PREMATURE EJACULATION

PRODUCT COMPOSITION
Premature Ejaculation
DAPOXETINE HYDROCHLORIDE 11% , 22% W/W 11,22%

PROKINETIC AGENT

PRODUCT COMPOSITION
Prokinetic agent
ITOPRIDE HCL SR PELLETS 150 MG 150mg

PROTONPUMP INHIBITOR

PRODUCT COMPOSITION
PROTONPUMP INHIBITOR
DEXLANSOPRAZOLE 20% W/W PELLETS 20%
DEXRABEPRAZOLE 20% W/W PELLETS 20%